278 related articles for article (PubMed ID: 10584978)
1. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
[TBL] [Abstract][Full Text] [Related]
2. Impact of amphotericin B on the cytochrome P450 system in HIV-infected patients.
Brockmeyer NH; Gambichler T; Bader A; Kreuter A; Kurowski M; Sander P; Altmeyer P
Eur J Med Res; 2004 Feb; 9(2):51-4. PubMed ID: 15090289
[TBL] [Abstract][Full Text] [Related]
3. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
4. Hepatic drug clearance in patients with mild cystic fibrosis.
Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE
Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M
Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934
[TBL] [Abstract][Full Text] [Related]
6. The influence of dietary restriction on the metabolism of theophylline and antipyrine in the ageing female BN/BiRij rat.
Groen K; Breimer DD; Brouwer A; Schijff G; Jansen EJ; van Bezooijen CF
J Pharmacol Exp Ther; 1995 Jul; 274(1):143-7. PubMed ID: 7616391
[TBL] [Abstract][Full Text] [Related]
7. Changes of antipyrine pharmacokinetics during influenza and after administration of interferon-alpha and -beta.
Brockmeyer NH; Barthel B; Mertins L; Goos M
Int J Clin Pharmacol Ther; 1998 Jun; 36(6):309-11. PubMed ID: 9660037
[TBL] [Abstract][Full Text] [Related]
8. Effect of zidovudine therapy in patients with HIV infection on endogenous interferon plasma levels and the hepatic cytochrome P450 enzyme system.
Brockmeyer NH; Barthel B; Mertins L; Goos M
Chemotherapy; 1998; 44(3):174-80. PubMed ID: 9612607
[TBL] [Abstract][Full Text] [Related]
9. Differential induction of cytochrome P450 isoforms and peroxisomal proliferation by cyfluthrin in male Wistar rats.
Anadón A; Martínez MA; Martínez M; Castellano V; Ares I; Romero A; Fernández R; Martínez-Larrañaga MR
Toxicol Lett; 2013 Jul; 220(2):135-42. PubMed ID: 23639246
[TBL] [Abstract][Full Text] [Related]
10. Antipyrine pharmacokinetics and urinary excretion in female horses.
Dyke TM; Sams RA; Hinchcliff KW
Am J Vet Res; 1998 Mar; 59(3):280-5. PubMed ID: 9522945
[TBL] [Abstract][Full Text] [Related]
11. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
[TBL] [Abstract][Full Text] [Related]
12. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
St Peter JV; Abul-Hajj Y; Awni WM
Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
[TBL] [Abstract][Full Text] [Related]
14. Modulation of antipyrine clearance by polysaccharide peptide (PSP) isolated from Coriolus versicolor in the rat.
Chan SL; Yeung JH
Food Chem Toxicol; 2006 Sep; 44(9):1607-12. PubMed ID: 16698162
[TBL] [Abstract][Full Text] [Related]
15. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.
van der Graaff M; Vermeulen NP; Joeres RP; Vlietstra T; Breimer DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725
[TBL] [Abstract][Full Text] [Related]
17. The effect of sex on antipyrine metabolism in cattle at different ages.
Janus K; Antoszek J
J Vet Pharmacol Ther; 1999 Jun; 22(3):163-9. PubMed ID: 10447826
[TBL] [Abstract][Full Text] [Related]
18. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
[TBL] [Abstract][Full Text] [Related]
19. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD
J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489
[TBL] [Abstract][Full Text] [Related]
20. The influence of aging on the metabolism of simultaneously administered hexobarbital enantiomers and antipyrine before and after phenobarbital induction in male rats: a longitudinal study.
Groen K; Breimer DD; Jansen EJ; van Bezooijen CF
J Pharmacol Exp Ther; 1994 Feb; 268(2):531-6. PubMed ID: 8113964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
